Orphan Drugs

Orphan pharmaceuticals are prescription medications used to treat rare illnesses or disorders that are meant to be treated, prevented from occurring, or diagnosed. They are referred to as "orphan medications" due to the small size of their market. A illness is considered an orphan if it affects fewer than 200,000 persons nationally. The majority of orphan diseases have a genetic basis. Orphan diseases are rare and could impact one in every 15 people worldwide.

 

    Related Conference of Orphan Drugs

    June 12-13, 2023

    19th World Congress on Infection Prevention and Control

    Edinburgh, Scotland
    August 07-08, 2023

    5th World Congress on Advancements in Tuberculosis and Lung Diseases

    Singapore City, Singapore
    August 07-08, 2023

    6th Global Experts Meeting on Infectious Diseases

    Singapore City, Singapore
    August 09-10, 2023

    18th World Congress on Virology, Emerging Diseases & Vaccines

    Amsterdam, Netherlands
    August 30-31, 2023

    19th International Conference on Infectious Diseases

    Amsterdam, Netherlands
    September 11-12, 2023

    16th World Congress on Virology and Infectious Diseases

    Singapore City, Singapore
    September 11-12, 2023

    15th Global Conference on Nephrology and Infectious Diseases

    Singapore City, Singapore
    September 25-26, 2023

    14th International Conference on Emerging Infectious Diseases

    Zurich, Switzerland
    September 27-28, 2023

    32nd International Conference on Coronary Diseases

    Zurich, Switzerland
    October 09-10, 2023

    15th Euro-Global Conference on Infectious Diseases

    Zurich, Switzerland
    October 25-26, 2023

    13th International Conference on GI Disorders

    Vancouver, Canada
    December 07-08, 2023

    6th Pathology and Infectious Disease Conference

    Prague, Czech Republic

    Orphan Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in